Peter Lynch fit · Growth at a reasonable price (GARP)
Is BioCryst Pharmaceuticals, Inc. (BCRX) a Peter Lynch Stock?
Strong GARP candidate - growth at a reasonable price.
71/100
BProvável ação Lynch
4/6 critérios atendidos
Os critérios de Peter Lynch, aplicados a BCRX
PEG ≤ 1.0
chave-
EPS CAGR ≥ 15%
chave-
Revenue CAGR ≥ 10%
53.6%
Net margin > 0
30.2%
Como BCRX pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$1.74B
P/L (TTM)
-
ROIC (TTM)
-121.96%
Margem bruta
18.89%
Outras análises Peter Lynch
Perguntas frequentes
What is BCRX's Peter Lynch fit score?
BCRX scores 71/100 on our Peter Lynch fit engine - grade B. Strong GARP candidate - growth at a reasonable price.
Does Peter Lynch actually own BCRX?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends BCRX.
How often is this score updated?
BCRX's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Peter Lynch possua ou recomende BCRX pessoalmente.